Eagle Pharmaceuticals Inc
NASDAQ:EGRX
Income Statement
Earnings Waterfall
Eagle Pharmaceuticals Inc
Revenue
|
257.5m
USD
|
Cost of Revenue
|
-77.6m
USD
|
Gross Profit
|
179.9m
USD
|
Operating Expenses
|
-143.8m
USD
|
Operating Income
|
36.1m
USD
|
Other Expenses
|
-24m
USD
|
Net Income
|
12.1m
USD
|
Income Statement
Eagle Pharmaceuticals Inc
Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||||||||||
Revenue |
14
N/A
|
15
+11%
|
20
+33%
|
21
+3%
|
19
-9%
|
19
+1%
|
51
+163%
|
51
+0%
|
54
+6%
|
66
+24%
|
60
-10%
|
94
+59%
|
127
+34%
|
190
+50%
|
237
+25%
|
246
+4%
|
271
+10%
|
237
-13%
|
207
-13%
|
216
+4%
|
204
-5%
|
213
+5%
|
217
+2%
|
214
-1%
|
204
-5%
|
196
-4%
|
192
-2%
|
177
-8%
|
186
+5%
|
188
+1%
|
183
-3%
|
189
+3%
|
179
-5%
|
172
-4%
|
246
+44%
|
272
+11%
|
298
+10%
|
317
+6%
|
267
-16%
|
258
-4%
|
|
Gross Profit | |||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(7)
|
(10)
|
(14)
|
(13)
|
(12)
|
(12)
|
(14)
|
(16)
|
(18)
|
(16)
|
(24)
|
(33)
|
(39)
|
(55)
|
(59)
|
(61)
|
(62)
|
(57)
|
(51)
|
(56)
|
(57)
|
(62)
|
(63)
|
(66)
|
(68)
|
(61)
|
(56)
|
(47)
|
(45)
|
(46)
|
(49)
|
(46)
|
(43)
|
(42)
|
(59)
|
(72)
|
(88)
|
(95)
|
(85)
|
(78)
|
|
Gross Profit |
6
N/A
|
5
-25%
|
6
+34%
|
8
+33%
|
7
-12%
|
8
+1%
|
36
+384%
|
35
-4%
|
36
+4%
|
51
+40%
|
35
-30%
|
62
+76%
|
87
+41%
|
134
+54%
|
178
+33%
|
185
+4%
|
209
+13%
|
180
-14%
|
156
-13%
|
160
+3%
|
147
-8%
|
151
+3%
|
153
+1%
|
148
-3%
|
136
-8%
|
135
-1%
|
137
+1%
|
130
-5%
|
142
+9%
|
142
+0%
|
135
-5%
|
143
+6%
|
137
-4%
|
129
-5%
|
187
+45%
|
200
+7%
|
211
+5%
|
222
+5%
|
183
-18%
|
180
-1%
|
|
Operating Income | |||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(15)
|
(9)
|
(10)
|
(17)
|
(26)
|
(30)
|
(35)
|
(39)
|
(41)
|
(48)
|
(55)
|
(60)
|
(63)
|
(83)
|
(91)
|
(106)
|
(110)
|
(97)
|
(112)
|
(105)
|
(105)
|
(104)
|
(107)
|
(92)
|
(101)
|
(113)
|
(123)
|
(122)
|
(116)
|
(109)
|
(109)
|
(111)
|
(130)
|
(127)
|
(121)
|
(122)
|
(111)
|
(119)
|
(154)
|
(144)
|
|
Selling, General & Administrative |
(5)
|
(3)
|
(5)
|
(6)
|
(9)
|
(12)
|
(14)
|
(17)
|
(18)
|
(20)
|
(27)
|
(34)
|
(41)
|
(52)
|
(60)
|
(72)
|
(76)
|
(71)
|
(69)
|
(61)
|
(58)
|
(61)
|
(64)
|
(65)
|
(69)
|
(76)
|
(83)
|
(84)
|
(83)
|
(79)
|
(74)
|
(72)
|
(73)
|
(75)
|
(78)
|
(78)
|
(80)
|
(85)
|
(91)
|
(102)
|
|
Research & Development |
(10)
|
(8)
|
(11)
|
(14)
|
(17)
|
(18)
|
(21)
|
(22)
|
(23)
|
(28)
|
(28)
|
(26)
|
(22)
|
(30)
|
(31)
|
(34)
|
(40)
|
(33)
|
(42)
|
(51)
|
(48)
|
(44)
|
(34)
|
(27)
|
(32)
|
(37)
|
(40)
|
(38)
|
(33)
|
(31)
|
(36)
|
(38)
|
(57)
|
(51)
|
(43)
|
(45)
|
(31)
|
(34)
|
(37)
|
(36)
|
|
Other Operating Expenses |
0
|
0
|
6
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
7
|
0
|
7
|
1
|
1
|
(10)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(26)
|
(6)
|
|
Operating Income |
(9)
N/A
|
(4)
+48%
|
(4)
+11%
|
(8)
-110%
|
(19)
-129%
|
(22)
-19%
|
1
N/A
|
(4)
N/A
|
(5)
-33%
|
3
N/A
|
(20)
N/A
|
2
N/A
|
25
+1 261%
|
52
+111%
|
87
+69%
|
79
-9%
|
99
+25%
|
83
-16%
|
44
-47%
|
55
+27%
|
42
-25%
|
47
+14%
|
47
-1%
|
56
+20%
|
35
-38%
|
22
-38%
|
14
-38%
|
8
-40%
|
26
+221%
|
33
+27%
|
25
-24%
|
32
+28%
|
7
-80%
|
3
-58%
|
66
+2 268%
|
78
+17%
|
100
+29%
|
102
+2%
|
28
-73%
|
36
+29%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(3)
|
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
4
|
(1)
|
(3)
|
(7)
|
(15)
|
(11)
|
(10)
|
(13)
|
(12)
|
(12)
|
|
Non-Reccuring Items |
4
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
0
|
0
|
(7)
|
(9)
|
0
|
(17)
|
(10)
|
(11)
|
0
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(20)
|
(23)
|
(26)
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
(6)
|
(4)
|
(10)
|
(8)
|
(2)
|
(4)
|
2
|
0
|
1
|
(7)
|
(18)
|
(2)
|
(2)
|
5
|
|
Pre-Tax Income |
(7)
N/A
|
(2)
+71%
|
(6)
-200%
|
(10)
-62%
|
(19)
-99%
|
(23)
-17%
|
2
N/A
|
(4)
N/A
|
(5)
-33%
|
3
N/A
|
(18)
N/A
|
4
N/A
|
26
+631%
|
53
+103%
|
87
+63%
|
79
-9%
|
91
+15%
|
73
-20%
|
42
-42%
|
36
-15%
|
29
-19%
|
34
+18%
|
44
+31%
|
54
+22%
|
34
-37%
|
22
-35%
|
7
-68%
|
3
-54%
|
15
+345%
|
23
+54%
|
27
+19%
|
27
+0%
|
6
-80%
|
(5)
N/A
|
52
N/A
|
40
-22%
|
49
+22%
|
61
+25%
|
14
-77%
|
29
+109%
|
|
Net Income | |||||||||||||||||||||||||||||||||||||||||
Tax Provision |
1
|
0
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
0
|
0
|
(0)
|
(1)
|
28
|
18
|
18
|
9
|
(18)
|
(7)
|
(2)
|
3
|
(2)
|
(6)
|
(12)
|
(8)
|
(8)
|
(5)
|
(8)
|
(10)
|
(11)
|
(13)
|
(9)
|
0
|
(4)
|
(16)
|
(18)
|
(28)
|
(26)
|
(17)
|
(17)
|
|
Income from Continuing Operations |
(6)
|
(2)
|
(5)
|
(8)
|
(18)
|
(20)
|
2
|
(3)
|
(4)
|
3
|
(18)
|
3
|
25
|
82
|
105
|
97
|
100
|
55
|
35
|
33
|
32
|
32
|
38
|
42
|
26
|
14
|
2
|
(5)
|
5
|
12
|
15
|
18
|
6
|
(9)
|
36
|
23
|
21
|
36
|
(3)
|
12
|
|
Net Income (Common) |
(10)
N/A
|
(5)
+46%
|
(9)
-60%
|
(11)
-31%
|
(20)
-77%
|
(21)
-6%
|
2
N/A
|
(3)
N/A
|
(4)
-35%
|
3
N/A
|
(18)
N/A
|
3
N/A
|
25
+694%
|
82
+221%
|
105
+29%
|
97
-8%
|
100
+4%
|
52
-48%
|
32
-39%
|
30
-6%
|
28
-5%
|
32
+12%
|
38
+20%
|
42
+10%
|
26
-39%
|
14
-45%
|
2
-83%
|
(5)
N/A
|
5
N/A
|
12
+145%
|
15
+21%
|
18
+27%
|
6
-69%
|
(9)
N/A
|
36
N/A
|
23
-36%
|
21
-7%
|
36
+67%
|
(3)
N/A
|
12
N/A
|
|
EPS (Diluted) |
-0.71
N/A
|
-0.38
+46%
|
-0.95
-150%
|
-0.79
+17%
|
-1.97
-149%
|
-1.47
+25%
|
0.14
N/A
|
-0.2
N/A
|
-0.26
-30%
|
0.16
N/A
|
-1.17
N/A
|
0.19
N/A
|
1.54
+711%
|
4.96
+222%
|
6.48
+31%
|
6
-7%
|
6.33
+6%
|
3.26
-48%
|
2.03
-38%
|
1.93
-5%
|
1.83
-5%
|
2.09
+14%
|
2.65
+27%
|
2.97
+12%
|
1.89
-36%
|
1.01
-47%
|
0.17
-83%
|
-0.33
N/A
|
0.35
N/A
|
0.87
+149%
|
1.1
+26%
|
1.38
+25%
|
0.43
-69%
|
-0.66
N/A
|
2.77
N/A
|
1.78
-36%
|
1.61
-10%
|
2.73
+70%
|
-0.19
N/A
|
0.91
N/A
|